07:00 , Mar 24, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Hepatic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Liver disease Neurocan (NCAN); glucokinaseregulator (GCKR; GKRP); lysophospholipase-like 1 (LYPLAL1); patatin-like phospholipase domain containing 3 (PNPLA3) Genomewide association studies identified...